Evidence map›Paper›PMID 42826505›Full record

ArticleBioinformatics (Oxford, England)2026

Multi-objective-conditioned-return-blocks decision transformer: a novel approach for multi-objective de novo drug design.

Eyal Mazuz, Or Gindes, Lior Rokach, Bracha Shapira

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eyal MazuzFaculty of Computer and Information Sciences, Ben-Gurion University of the Negev, Be'er Sheva 8410501, Israel.ORCID 0009-0001-1077-1736
Or GindesFaculty of Computer and Information Sciences, Ben-Gurion University of the Negev, Be'er Sheva 8410501, Israel.
Lior RokachFaculty of Computer and Information Sciences, Ben-Gurion University of the Negev, Be'er Sheva 8410501, Israel.
Bracha ShapiraFaculty of Computer and Information Sciences, Ben-Gurion University of the Negev, Be'er Sheva 8410501, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

motivationDesigning novel molecules that simultaneously satisfy several, often conflicting, properties is a long-standing challenge in drug design. While recent deep learning advances optimize single targets effectively, navigating the tradeoffs required for multiple objectives remains a difficult problem.

resultsWe introduce the Multi-Objective-Conditioned-Return-Blocks Decision Transformer (M-GoRT), a novel architecture for multi-target de-novo drug design incorporating return-to-go blocks conditioned on goal embeddings. Trained without exploration, reward weighting or online fine-tuning, M-GoRT efficiently optimizes for multiple targets. M-GoRT achieves competitive multi-objective success rates against state-of-the-art baselines while maintaining superior structural diversity and novelty, even in high-dimensional tasks incorporating biological targets (DRD2, JNK3). In these high-dimensional tasks, M-GoRT maintains superior structural diversity and novelty establishing it as a practical tool for multi-property molecular generation. AVAILABILITY AND IMPLEMENTATION: M-GoRT and the data used are freely available as an open-source software under the MIT license at GitHub https://github.com/eyalmazuz/MolGen/tree/GCRB-DT.

Indexed as

Computational BiologyDeep LearningDrug DesignSoftwareAlgorithms

Identifiers

PMID42826505
PMCPMC13674356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.